UCSD Patient Gets First Cancer Treatment Made From Stem Cells

April 14, 2019by Bradley J. Fikes
A tray of stem cells at the University of Connecticut's Stem Cell Institute at the UConn Health Center on August 27, 2010, in Farmington, Conn. (Spencer Platt/Getty Images/TNS) **FOR USE WITH THIS STORY ONLY**

SAN DIEGO — A new form of cancer immunotherapy has been given to a University of California, San Diego Health patient in the first test of immune cells grown from stem cells.

The patient, Derek Ruff, is being treated for stage four colon cancer, which recurred after a decade in remission. The disease continued to progress despite chemotherapy and radiation, said UCSD’s Dr. Sandip Patel, who treated Ruff.

Ruff is getting infusions of what are called “natural killer” or NK cells, made by San Diego’s Fate Therapeutics. Fate has worked closely with UCSD’s Dr. Dan Kaufman, an expert on these cells.

Ruff began getting multiple doses of NK cells in February. In early April, he said the immunotherapy hasn’t debilitated him like previous treatments.

“Before I got the first treatment, I was very apprehensive,” said Ruff, 52. “I had been through a lot of chemo, and chemo makes you feel really bad.”

It has yet to be determined if the NK cell treatment, called FT500, is working.

Fate is testing these NK cells in patients with advanced solid tumors, where a better-known cell therapy called chimeric antigen receptor, or CAR T cells, has shown limited benefit.

CAR T cells are genetically engineered to detect a specific molecular marker on the cancer cells. These cells have revolutionized cancer treatment, especially for blood cancers. Two approved treatments are available, Kymriah and Yescarta.

But the CAR T cells must be custom-made from the patient’s own cells, an expensive process that takes weeks. And they haven’t been extensively tested against solid tumors, such as Ruff’s.

Patel said he was particularly excited by the idea of treating solid tumors with NK cell therapies.

“Patients with solid tumors are the biggest population of patients that we see in aggregate, and are a major unmet need in terms of cellular immunotherapy,” Patel said.

FT500 is a first-of-kind product approved by the U.S. Food and Drug Administration for experimental use.

Unlike CAR T cells, which are custom-made from a patient’s own cells over a period of weeks, FT500 is produced in advance as an “off the shelf” treatment and doesn’t require immune matching. Due to economies of scale, “off-the-shelf” treatments are expected to cost less.

Fate starts with what are called induced pluripotent stem cells, or iPSCs. These are adult cells “reprogrammed” to resemble embryonic stem cells. These iPSCs are then matured into NK cells.

“This product is derived from a master bank of induced pluripotent stem cells that self-renew, and thus are able to continually make these NK cells,” Patel said. “If this works, patients can be treated en masse with these cells, given and administered like other drugs, but are living cellular products.”

———

©2019 The San Diego Union-Tribune

Visit The San Diego Union-Tribune at www.sandiegouniontribune.com

Distributed by Tribune Content Agency, LLC.

Health

Trump's Rushmore Trip Draws Real and Figurative Fireworks
Political News
Trump's Rushmore Trip Draws Real and Figurative Fireworks

SIOUX FALLS, S.D. (AP) — President Donald Trump will begin his Independence Day weekend on Friday with a patriotic display of fireworks at Mount Rushmore before a crowd of thousands, but even in a part of the country where many remain supportive of the president, the... Read More

Virus Concerns Grow — As Do Crowds Flocking to Jersey Shore
Health
Virus Concerns Grow — As Do Crowds Flocking to Jersey Shore

BELMAR, N.J. (AP) — As coronavirus-related restrictions are eased and temperatures climb, people are flocking back to the Jersey Shore. And with the July Fourth holiday weekend upon us, that's making some people nervous, particularly given the large crowds that have surfaced at some popular shore... Read More

Democrats Say US Needs to Address Protective Gear Shortage
Health
Democrats Say US Needs to Address Protective Gear Shortage

A congressional committee criticized President Donald Trump’s administration on Thursday for a series of problems in distributing personal protective and testing equipment during the coronavirus pandemic and called on the administration to come up with a better plan. “We need urgent action from the federal government... Read More

From Big Cities to Backyards, July 4 Not Usual Blowout Bash
In The News
From Big Cities to Backyards, July 4 Not Usual Blowout Bash

NEW YORK (AP) — The idea sounds almost un-American. The Fourth of July was always a time for communities to come together, daylong celebrations with patriotic parades in the morning and fireworks finales to cap it off. This year, people are being urged to stay home.... Read More

Fauci Warns US Needs to Reverse COVID-19 Trends
Health
Fauci Warns US Needs to Reverse COVID-19 Trends

WASHINGTON — The nation’s top infectious disease specialist warned Tuesday that the United States could see up to 100,000 new cases per day of the virus that causes COVID-19 if the nation does not take steps to control the pandemic. Anthony Fauci, the director of the... Read More

FDA Issues Guidance on Development of a Safe and Effective COVID-19 Vaccine
Health
FDA Issues Guidance on Development of a Safe and Effective COVID-19 Vaccine
June 30, 2020
by Dan McCue

WASHINGTON - The U.S. Food and Drug Administration released a series of recommendations Tuesday that it say should help facilitate the timely development of a safe and effective COVID-19 vaccine. The agency said the guidance reflects advice it has been providing over the "past several months"... Read More

News From The Well
scroll top